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Treating Proximal Tibial Growth Plate Injuries
Using Poly(Lactic-co-Glycolic Acid) Scaffolds
Amanda Clark,1 J. Zach Hilt,2 Todd A. Milbrandt,3,* and David A. Puleo1,*
Abstract
Growth plate fractures account for nearly 18.5% of fractures in children. Depending on the type and severity of
the injury, inhibited bone growth or angular deformity caused by bone forming in place of the growth plate can
occur. The current treatment involves removal of the bony bar and replacing it with a filler substance, such as a
free fat graft. Unfortunately, reformation of the bony bar frequently occurs, preventing the native growth plate
from regenerating. The goal of this pilot study was to determine whether biodegradable scaffolds can enhance
native growth plate regeneration following a simulated injury that resulted in bony bar formation in the proximal
tibial growth plate of New Zealand white rabbits. After removing the bony bar, animals received one of the fol-
lowing treatments: porous poly(lactic-co-glycolic acid) (PLGA) scaffold; PLGA scaffold loaded with insulin-like
growth factor I (IGF-I); PLGA scaffold loaded with IGF-I and seeded with autogenous bone marrow cells
(BMCs) harvested at the time of implantation; or fat graft (as used clinically). The PLGA scaffold group showed
an increased chondrocyte population and a reduced loss of the remaining native growth plate compared to
the fat graft group (the control group). An additional increase in chondrocyte density was seen in scaffolds
loaded with IGF-I, and even more so when BMCs were seeded on the scaffold. While there was no significant
reduction in the angular deformation of the limbs, the PLGA scaffolds increased the amount of cartilage and
reduced the amount of bony bar reformation.
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Introduction
The growth plate is a cartilaginous region of long bones
that is responsible for bone growth, which continues
until puberty when the influence of hormones causes
it to close.1–3 About 50% of children 5–18 years old
will experience a fracture, usually caused from trauma
or playing sports. Of those fractures, an estimated 18%
of the them will involve the growth plate, damage to
which can result in angular deformation or inhibited
growth.4 A reported 30–65% of growth plate fractures
resulted in some level of growth disturbance, depend-
ing on the type and location of the fracture.5
Growth plate injuries are so detrimental because the
cartilage is unable to regenerate,6 which leads to the
formation of bone at the place of fracture, referred to
as a bony bar (or bridge).7 The bony bar acts as a tether
that prevents certain areas of the physis from expand-
ing.8 To prevent impaired growth, current treatment
options involve removal of the bony bar and replace-
ment with fat, muscle, cartilage, polymeric silicone,
bone wax, or bone cement as interpositional materi-
als.9–11 The Langenskiöld method, which involves re-
moving the bony bridge and replacing it with a free
fat transplant, has been shown to be a better alternative
to osteotomy and limb lengthening.12 However, about
60% of patients who receive this treatment have fair
to poor results, and approximately 30% of patients ex-
perience a reoccurrence of bony bar formation.11
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Current research for other treatment options largely
surrounds the use of mesenchymal stem cells (MSCs).
Li et al. implanted chitin scaffolds cultured with
MSCs for 7 days into the medial half of the proximal
tibia growth plate of rabbits after excising the bony
bar. A significant decrease in angular deformation and
longitudinal discrepancy compared to the unoperated
tibia was reported.13 Similar results were seen in other
work involving sodium hyaluronate/collagen or agarose
scaffolds where limb length improved.14–16 The draw-
backs of this approach, however, are that MSCs must
first be harvested during an additional surgery as well
as the time needed for preculture on the scaffolds.
The objective of the present pilot animal study was to
determine whether previously developed poly(lactic-co-
glycolic acid) (PLGA) scaffolds loaded with insulin-like
growth factor I (IGF-I) enhance growth plate regenera-
tion compared to a currently used clinical treatment,
such as a fat graft.
Materials and Methods
Scaffold fabrication
Microspheres were fused to form porous PLGA (50:50,
molecular weight: 31–58 kDa, acid-terminated; Durect
Corporation, Pelham, AL) scaffolds as previously
reported.17 To fabricate the blank and IGF-I-loaded scaf-
folds (PeproTech, Rocky Hill, NJ), 120 mg of PLGA mi-
crospheres ( < 250 lm) were mixed with 180 mg of NaCl
particles ( < 150 lm) and compressed in a 6.5-mm-
radius die at 7 tons for 2 minutes using a Carver
press. The scaffolds were sintered for 48 h at 49C,
leached in deionized water overnight, and dried. The
scaffold was cut in half to better fit the implantation
site. The final dimensions of all the scaffolds were a
6.5-mm-radius semicircle with 1.2 mm height. The
IGF-I-loaded semicircle scaffolds contained 27–35 lg
of IGF-I.
For disinfection, each scaffold was placed in a 50 mL
centrifuge tube and centrifuged at 200 g for 5 min in
5 mL of 70% ethanol followed by two wash steps with
sterile PBS. The scaffolds were then dried in a laminar
flow hood overnight.
Animal surgery
All animal studies were conducted at the University of
Kentucky in accordance with a protocol approved by
the Institutional Animal Care and Use Committee
(IACUC). Fifteen New Zealand white female rabbits,
6–8 weeks old, were used. To simulate a growth plate
injury,13 the medial one-third of the proximal tibial
growth plate was removed unilaterally using a 1.0 mm
bur (Stryker Medical, Malvern, PA), as seen in Figure
1A and B. The wound was thoroughly irrigated with sa-
line and closed using sutures. Radiographic images were
taken to verify location of the growth plate defect. After
3 weeks, radiographs were obtained to confirm forma-
tion of a bony bar across the defect. The bony bar
was then resected using the same procedure described
previously, and an implant trimmed to fit the defect
was placed in the site (Fig. 1C). Animals were assigned
to one of four treatment groups: (1) fat, removed from
the infrapatellar fat pad; (2) blank (without IGF-I) scaf-
fold; (3) IGF-I-loaded scaffold; and (4) IGF-I-loaded
scaffold with bone marrow cells (BMCs) harvested at
the time of surgery (Fig. 2). An empty defect group
was not included in this study because a previous exper-
iment confirmed collapse of the tibial plateau and bridg-
ing with bone.18 For group 4, after removal of the bony
bar, bone marrow was aspirated from the implant site
and tibial diaphysis using a syringe, seeded onto the
FIG. 1. The site of implantation before (A) and after (B) growth plate removal. The black arrow indicates
intact growth plate. (C) Trimmed and implanted scaffold (white arrow) following resection of the bony bar.
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scaffold, and given 20 min for absorption. Upon recov-
ery, the animals were returned to their cages and
allowed to move freely with no immobilization. After
8 weeks, the animals were euthanized and another ra-
diograph was obtained.
Microcomputed tomography
At the end of the study, a 3D reconstruction of the
proximal tibia was created using a Scanco lCT40
(Scanco Medical, Zürich, Switzerland). Samples were
imaged at 6 lm voxel resolution using scan parame-
ters of 55 kV and 145 mA. The reconstructions were
used to qualitatively evaluate the ability of the scaf-
folds to prevent bone formation in and around the de-
fect area.
Anatomical measurements
The medial and lateral lengths of the tibiae and the
widths of fibulae were measured for each lower hind
limb. Also, using the radiographic images obtained at
the time of implantation and euthanasia, the medial
proximal tibial angle (MPTA) and lateral distal femoral
angle (LDFA) were determined (Fig. 3). All measure-
ments were calculated using ImageJ software.
Histological analysis
After removal of the fibulae, the proximal tibiae were
fixed in 10% buffered formalin for 2 weeks. Flagship
Biosciences (Aurora, CO) processed the samples by
bisecting the bones using the fibular insertion to
the opposite side as reference points and then decal-
cifying them in 10% formic acid. Coronal sections
were cut at 4 lm thickness and stained using hema-
toxylin and eosin. Stained sections were visualized
and photographed using a Nikon Eclipse E600 mi-
croscope attached to a Nikon DN 100 digital camera.
Observations were based on multiple slides prepared
for each specimen.
Statistical analysis
Analysis was carried out using GraphPad InStat soft-
ware running an ANOVA followed by a Tukey–Kramer
multiple comparisons test. Results were considered sig-
nificant if p < 0.05.
Results
Postoperative observations
Two of the rabbits became infected after scaffold im-
plantation, both in the IGF-loaded scaffold group. An
FIG. 2. Bone marrow was harvested from the diaphysis (A), seeded on scaffolds (B), and absorbed into the
scaffolds for 20 min (C).
FIG. 3. Medial proximal tibial angle (MPTA)
and lateral distal femoral angle (LDFA) shown on
radiograph.
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additional third rabbit in the cell-seeded, IGF-I-loaded
scaffold group showed signs of a possible infection but
was treated with antibiotics.
Microcomputed tomography
A bisected reconstruction of each proximal tibia is
shown in Figure 4. Varying amounts of bone growth
occurred in all of the noninfected limbs. There
appeared to be some bone forming around the implant
site in the other animals, especially in the blank and
IGF-I-loaded scaffold groups. One example is shown
in the yellow circle, indicating the implant site. The
black arrow in the figure illustrates a dense bone for-
mation at the implant site, representative of bony bar
formation. The small gap on the medial side, where
the defect site was created, may indicate a presence of
radiolucent cartilaginous tissue.
Anatomical measurements
The MPTA data are shown in Figure 5A. All treatments
resulted in an angle decrease 8 weeks after the implan-
tation surgery. The smallest MPTA at 8 weeks was in
the IGF-I-loaded scaffold group, which included the
two infected animals. The next lowest was the fat im-
plant group, followed by the cell-seeded, IGF-loaded
scaffold, and the blank scaffold. No statistical differ-
ences were seen between angles at the time of bony
bar resection and at 8 weeks following implantation
or between scaffold types.
Figure 5B shows the LDFA results, ranging from 90
to 96, where the fat implant group had the smallest
angle, and the cell-seeded, IGF-loaded group had the
largest angle at 8 weeks after implantation. The blank
scaffold and IGF-I-loaded scaffold groups fell in be-
tween, with no statistical difference between any groups.
FIG. 4. Cut-plane microcomputed tomography images of each tibia for the four treatment groups: (1) fat
implant, (2) blank scaffold, (3) IGF-I-loaded scaffold, and (4) cell seeded, IGF-I-loaded scaffold. The defects are
on the medial (left) side, and the native growth plate is on the lateral (right) side. The yellow circle indicates the
implant site; white arrow indicates the native growth plate; black arrow indicates bony bar formation; red
asterisks indicate infected or potentially defects.
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Histology
Numerous sections were cut to encompass the full
width of the epiphysis at the mid-plane of the tibia.
Thus, the region in which scaffolds were implanted
was well evaluated and representative results are
shown. Neither chronic inflammation nor fibrous tis-
sue was observed in any of the specimens.
Figure 6 shows rabbit tibiae sectioned in the coronal
plane at 8 weeks after implantation. The remnant of the
native growth plate can be seen on the right side of all
the images (the lateral side, L), while the implant site
can be seen on the left (or medial side, M). The contra-
lateral right legs, which were not injured, served as con-
trol (Fig. 6A). A distinct growth plate can be readily
seen across the width of the tibia. Defects treated with
fat grafts showed a dense region of bone on the medial
side where tissue had regrown (Fig. 6B). Compared to
the fat graft group, defects treated with a blank scaffold
had a wider growth plate across the tibia (Fig. 6C).
Treatment with IGF-I-loaded scaffolds, both with and
without seeded cells, maintained a structured growth
plate on the lateral side and an increased density of
chondrocytes on the medial side in areas (Fig. 6D).
The addition of BMCs resulted in a large, dense area
of cartilage on the upper medial side containing mostly
hypertrophic chondrocytes (Fig. 6E).
FIG. 5. Medial proximal tibial angles (A) and
lateral distal femoral angles (B) at 3 weeks after
growth plate injury (before resection of the bony
bar) and 8 weeks after implantation of scaffold.
Data are shown as means – standard error (n ‡ 3).
FIG. 6. Representative histological images of (A) normal proximal tibial growth plate and proximal tibiae
following treatment of defects with (B) fat implant, (C) blank scaffold, (D) IGF-loaded scaffold, and (E) cell-
seeded, IGF-I-loaded scaffold. For images (B–E), the defects were on the medial (left) side, and the native
growth plate is on the lateral (right) side. The black circle indicates an area of bone formed within the defect;
the black arrow indicates a wide region of newly formed cartilage; red arrows indicate isolated areas of
cartilage; and the yellow circle indicates a large, dense area of cartilage.
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Magnified views of selected samples are shown in
Figures 7–10, where the specific zones of the chondro-
cytes (reserve, proliferative, hypertrophic, or calcifica-
tion zones) could be identified. The reserve (R)
chondrocytes were recognized by their smaller size,
uniformly spherical appearance. Proliferative (P) chon-
drocytes were observed more frequently in longitudinal
columns with increasing volume of cytoplasm. Hyper-
trophic (H) chondrocytes zone were identified based
on their larger, spherical shape that eventually gave
way to nuclear fragmentation as they entered the calci-
fication (C) zone. Figure 7 shows the results of the fat
implant with a thin, but continual, connection of carti-
lage spanning the width of the tibia, where different
chondrocytes phenotypes were seen. A defect treated
with a blank scaffold had a thicker continual connec-
tion of chondrocytes (labeled in Figure 8B) with stria-
tions of cartilage below the growth plate area, while the
center of the tibia had thin patches of mostly hypertro-
phic chondrocytes. Treatment with IGF-I-loaded scaf-
folds resulted in pockets of chondrocytes throughout
the medial half of the tibia (Fig. 9). The effect of a
cell-seeded, IGF-loaded scaffold is shown in Figure
10, with a large pocket of chondrocytes on the upper
medial side containing mostly hypertrophic chondro-
cytes surrounded by reserve cells (Fig. 10).
Discussion
This preliminary study was performed to evaluate
PLGA scaffolds for regenerating growth plate without
using previously harvested MSCs but instead seeding
BMCs aspirated from the tibia during the same sur-
gery of implanting the scaffold. The material was se-
lected based on previous research with a lower
molecular weight PLGA. Increasing the molecular
weight was expected to not only give more structural
support to withstand physiologic conditions and
thereby allow more time for new growth plate tissue
to develop. Additionally, the scaffolds were loaded
with IGF-I, which has been shown to increase cell pro-
liferation and increase glycosaminoglycan content, an
important cartilage component, production over
time.17 Compared to the clinically relevant implanta-
tion of fat, the use of PLGA scaffolds, with and with-
out IGF-I and BMCs, increased the chondrocytes
population and amount of overall cartilage in the
epiphyseal plate.
FIG. 7. Fat implant showed thin, continual line
of cells across medial side that contained reserve
(R), proliferative (P), hypertrophic (H) cartilage
cells, and calcification zones (C).
FIG. 8. Blank scaffold on (A) the lateral side
with columnar structure and (B) the medial side
with the appearance of stacked (S), reserve (R),
proliferative (P), and hypertrophic (H) cartilage
cells.
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Polymer and implant selection
In the present study, the molecular weight of the PLGA
was *30 kDa, which was an increase compared to
previous work.19 Previously, scaffolds composed of
*6 kDa PLGA degraded too quickly and allowed col-
lapse of the tibial plateau. Even so, implantation of
lower molecular weight PLGA scaffolds resulted in
the presence of chondrocytes after 2 weeks with a fur-
ther increase in rabbits treated with IGF-I-loaded scaf-
folds. Using a higher molecular weight was postulated
to increase structural support to the implant site and
allow more tissue regrowth to occur before the scaffold
degraded.
PLGA-based scaffolds were chosen because PLGA
has been shown to be biocompatible and biodegrad-
able.20,21 Drug delivery devices using PLGA micro-
spheres are already FDA approved, such as Lupron
Depot, Zoladex, and Atridox, for the treatment of pros-
tate cancer, endometriosis, and fibroids. The mechani-
cal properties of PLGA scaffolds were shown to be
suitable for hard and soft tissue implants with an initial
compressive modulus of about 100 MPa.17
To evaluate the success of a polymeric scaffold for
growth plate regeneration, a fat implant was chosen to
represent current clinical practice by using the Langen-
skiöld method in which the bony bar is excised and
replaced with transplanted fat.10,12,22 Free fat transplants
act as a space-filler that slowly undergoes ossification in
an attempt to prevent total growth plate closure, but re-
sults are fair to poor in *60% of patients.11,23
Growth factors have been theorized to enhance car-
tilage regeneration by increasing cell proliferation and
decreasing cell apoptosis. Delivery of IGF-I has been
shown to enhance bone and cartilage production
in vivo.9,24–28 For this reason, IGF-I was loaded into
the PLGA microspheres used to fabricate the scaffolds
for this study. Recent investigations demonstrated re-
tention of IGF-I bioactivity during scaffold fabrication,
which includes fusion of microspheres at 49C.29 Seed-
ing BMCs onto the scaffold was performed in an effort
to add mesenchymal cells to the implant site directly
instead of waiting for cell recruitment and proliferation
during recovery.
Anatomical measurements
Growth plate injury causes a decrease in both the
MPTA and LDFA; therefore, the larger the angle, the
better the recovery. The MPTA and LDFA were both
lowest in the fat implant group (regardless of whether
the infected animals were included or excluded), and
although results were not significant, this may indicate
that the fat graft does not correct angular deformation
as well as the polymeric scaffolds. Surprisingly, the
highest MPTA and second highest LDFA were seen
in the blank scaffold group. A similar trend was seen
in previous work during an 8-week study, where the
FIG. 9. IGF-I-loaded scaffold showed dispersed
pockets of cartilage cells throughout the medial
side with the appearance of reserve (R),
proliferative (P), hypertrophic (H), and
degenerative states (D).
FIG. 10. IGF-I-loaded scaffolds with cells
showed a large dense population of
chondrocytes on the medial side with the
appearance of reserve (R), proliferative (P),
hypertrophic (H), and degenerative states (D).
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blank scaffold group had a higher angle than the other
treatment types, although results were not significant.18
It should be noted that all measurements were calcu-
lated by hand, which contributes to larger errors.
Other groups have reported statistical differences, but
their studies lasted twice as long as the current study.
For example, Planka et al. used MSCs seeded onto so-
dium hyaluronate/collagen scaffolds in a distal femur
model and found a 0.50 – 0.04 cm increase in bone
length and an LDFA lowered by 3.6–4.5 over the con-
trol at 4 months following implantation.16 Their con-
trol was no implant as compared to the clinically
relevant fat implant used in the present study. In previ-
ous work, an empty control group, which received no
implant, resulted in bone formation at the implant
site 8 weeks after operation and showed the lowest
amount of angular correction.18
Eight weeks after implantation, defects treated with
BMCs showed a greater presence of chondrocytes, yet
no preculture time or additional surgery was required
to harvest the cells. Li et al. have shown that chitin-
based scaffolds with and without MSCs corrected an-
gular deformation significantly after 16 weeks,13 but
while Chen et al. reported increased angle recovery
and tibial length with MSCs seeded on agarose, agarose
alone gave poor results.14,15 A major difference be-
tween the mentioned scaffolds is their mechanical
properties. Agarose, collagen, and hyaluronan are com-
monly used in tissue engineering but have a low com-
pressive modulus, in the 1–150 kPa range, whereas
chitosan and PLGA scaffolds have a compressive mod-
ulus of 750 kPa to 100 MPa.17,30–34
Within tissue engineering research, PLGA scaffolds
with and without growth factors have been shown to
create a microenvironment necessary for proliferation
and chondrogenic differentiation of MSCs.11,22,23,35
Also, the PLGA scaffolds used in this study had a
pore size of 50–100 lm, shown to be applicable for
cell ingrowth.36 Therefore, as long as some of the
neighboring native growth plate cells remain viable or
MSCs are around the defect site, the scaffold may be
adequate to prevent bony bridge formation and allow
for growth plate regeneration. Incorporating IGF-I or
another type of growth factor into the scaffold may
provide the cellular signals necessary to initiate tissue
regrowth as discussed later.
Although the angle measurements did not show
complete correction of the limb deformation, micro-
computed tomography images showed that bone had
not completely filled the implant site comparable to
the fat implant, the current clinical practice, indicating
that bony bar reformation was inhibited. Bony bar for-
mation is one of the major complications associated
with growth plate injures.35,37 Limb length discrepancy
and angular deformation occurred in 58% of distal
femur factures involving the growth plate.5 Even with
the current clinical treatment of fat grafts, bony bridge
reformation has been shown to occur nearly 30% of the
time.11 Johnstone et al. used a type I collagen paste con-
taining osteogenic protein-1 and found promising limb
growth until bony bridge formation prevented further
growth.38
Histology
The attempt to regenerate the growth plate did not re-
sult in layered structure (epiphyseal to metaphyseal
zones) to the degree of the native growth plate, regard-
less of the treatment type. It appeared that the fat im-
plant allowed for some cartilage regeneration, but it
was only cell-wide at most points, and most of the
chondrocytes had the phenotype of cells in the calcifi-
cation zone. The tissue surrounding the cartilaginous
areas was woven bone, which appears after frac-
tures.39,40 The blank scaffold treatment resulted in tis-
sue having a structure similar to that for the fat implant
group with a couple exceptions. First, there were areas
where the scaffolds were replaced with some cellular
stacking, and second, the lateral side retained more
structure, resembling that of the native growth plate,
compared to defects treated with fat graft. Scaffolds
gave the epiphyseal region more structural support, re-
ducing further destruction of the native lateral growth
plate.
Defects treated with IGF-I-loaded scaffolds, both
with or without seeded cells, showed a similar appear-
ance on the lateral (native group plate) side as that of
the blank scaffold group, however, the medial sides
were quite different. Without cells, the IGF-I-loaded
scaffold resulted in pockets of chondrocytes through-
out the medial side along the epiphyseal line that con-
tained cells in all zones of cartilage development. The
addition of cells created a large vertical pocket (about
3 mm long) of chondrocytes located in the upper
epiphyseal region. Note, however, that interpretation
of the IGF-I-loaded samples was limited because only
one sample could be used for observation. The cells
were mostly in the hypertrophic state and had no co-
lumnar organization. Because the immunoinflamma-
tory response to infection will alter wound healing,
those specimens were not evaluated histologically.
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Both types of IGF-I-loaded scaffolds (with and without
cells seeding) increased the density of hypertrophic
chondrocytes compared to the fat and blank groups.
Cells seeded on scaffolds containing IGF-I created the
largest population of chondrocytes, which was to be
expected based on the literature surrounding IGF-I.41
One such example is from Masters et al., who showed
that IGF-I mediates chondrogenesis of BMCs through
increased cell proliferation and expression of chondro-
cyte markers.34
Certain types of PLA and PLGA implants have been
reported to elicit a foreign body response, whether as a
result of particulates or acidity generated during degra-
dation.42,43 Chronic inflammation and fibrous encapsu-
lation were not observed in the present study, however.
The porous nature of the scaffolds allowed exchange to
reduce acid buildup, and although an early presence of
inflammation cannot be excluded, observation of the
implantation sites after complete scaffold degradation
showed formation of either cartilage or bone. Addition-
ally, the responses seen in the scaffold groups did not
differ from that seen in the autologous fat graft group,
which reflects a current clinical treatment.
Compared to the study of Chen et al.,14 which lasted
for 16 weeks, the histological results for this 8-week
study are encouraging, having similarity in the types
of cells present, although without columnar structure.
Without MSCs, the hyaluronate/collagen, agarose,
and chitin scaffolds had either similar hypertrophic
pockets of chondrocytes or minimal presence of chon-
drocytes at all.13–16 However, the use of MSCs seeded
on the chitin or agarose scaffolds gave more of a colum-
nar structure but had twice as much time to develop
compared to samples in the present study.13
Conclusions
The goal of this study was to evaluate the potential of a
biodegradable scaffold to enhance regeneration of the
growth plate without preculture with MSCs. All types
of PLGA scaffolds tested led to better retention of the
lateral native growth plate compared to the current
clinical treatment of using fat grafts. Incorporating
IGF-I into the scaffolds increased the presence of chon-
drocytes at the defect site. Further enhancement of car-
tilage formation was observed with the addition of
BMCs collected at the time of the surgery to IGF-I-
loaded scaffolds. Angular deformation did not recover
significantly after 8 weeks regardless of the treatment
type, however, the histological results indicated that
the necessary cells were present for growth plate regen-
eration. This study showed that growth factor-loaded
PLGA scaffolds were not only as effective as the current
fat graft treatment in growth plate regeneration, but
they also enhanced the chondrocyte population at the
implant site and decreased the destruction of the
remaining native growth plate.
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22. Langenskiöld A, Österman K, Valle M. Growth of fat grafts after operation
for partial bone growth arrest: demonstration by computed tomography
scanning. J Pediatr Orthoped. 1987;7:389–394.
23. Foster BK, John B, Hasler C. Free fat interpositional graft in acute physeal
injuries: the anticipatory Langenskiöld procedure. J Pediatr Orthoped.
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